Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Ventas, Inc. (VTR) demonstrates strong performance in senior housing amid rising rates. Strategic initiatives and dividend increase signal confidence. Read the analysis.
Ventas, Inc. (VTR) is strategically positioned in the senior housing market. Strong Q4 earnings, Brookdale agreements, and a dividend increase highlight financial strength.
Ventas (VTR) Q4 2024 earnings beat estimates, driven by SHOP performance and a dividend hike, signaling strength. Interest rate sensitivity remains a key risk.
A deep dive into Ventas, Inc.'s Q4 2024 performance, dividend strategy, Brookdale lease amendment, and outlook in the healthcare REIT sector.
Ventas, Inc. (VTR) reported strong Q4 2024 earnings driven by its SHOP portfolio and increased its dividend, signaling financial confidence. The company strategically navigates the evolving healthcare REIT landscape.
Ventas Inc. (VTR) exceeded Q4 2024 expectations with robust SHOP performance, strong financials, and a confident dividend increase.